KYODO NEWS IMAGELINK

報道写真の購入なら共同通信イメージズ

  • 令和
  • 新型コロナウイルス
  • マスク
  • 感染症
  • 母乳
  • インフルエンザウイルス
  • ベンチャー
  • 世界初
  • 会見
  • 価格

「ナノ粒子」の写真・グラフィックス・映像

絞り込み
  • 提供元
  • 日付
  • 種類
  • 向き
  • カテゴリ
並び順
  • 古い順
63
( 1 63 件を表示)
  • 1
63
( 1 63 件を表示)
絞り込み
並び順
  • 古い順
  • 2005年06月17日
    影響を調べる実験装置 ナノ粒子の影響調査へ

    自動車排出ガスに含まれるナノ粒子が生物の体に及ぼす影響を調べる実験装置=17日、茨城県つくば市の国立環境研究所

    商品コード: 2005061700157

  • 2016年09月09日
    説明する東阪助教 母乳介し子へもナノ粒子

    記者会見で説明する大阪大の東阪和馬助教=9日午後、大阪市

    商品コード: 2016090900784

  • 2016年09月09日
    母乳介し子へもナノ粒子

    ナノ粒子が母乳を介して母マウスから子マウスに移行するイメージ

    商品コード: 2016090900940

  • 2016年09月09日
    母乳介し子へもナノ粒子

    ナノ粒子が母乳を介して母マウスから子マウスに移行するイメージ

    商品コード: 2016090900939

  • 2017年03月07日
    がん患部標的の粒子開発

    ナノ粒子が、がん患部にとどまるイメージ

    商品コード: 2017030700930

  • 2017年03月07日
    がん患部標的の粒子開発

    ナノ粒子が、がん患部にとどまるイメージ

    商品コード: 2017030700931

  • 2017年03月07日
    がん患部標的の粒子開発

    ナノ粒子が、がん患部にとどまるイメージ

    商品コード: 2017030700932

  • 2017年03月07日
    がん患部標的の粒子開発

    ナノ粒子が、がん患部にとどまるイメージ

    商品コード: 2017030700934

  • 2018年11月07日
    Award of the Berlin Science Prize 2018

    07 November 2018, Berlin: Daniela Rupp, Leibnitz Young Investigators Group Leader at the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy, is at the award ceremony for the Berlin Science Prize 2018 and the Young Investigators Prize 2018 in the Rotes Rathaus. Rupp was awarded the Young Investigators Prize 2018 of the Berlin Science Prize for her current research in attosecond physics, also known as ultra-short time physics. In a number of projects, she and her team have been able to make progress in understanding the imaging and interaction of nanometer-sized particles using intense X-ray pulses. Photo: Christoph Soeder/dpa、クレジット:DPA/共同通信イメージズ

    商品コード: 2018110925443

  • 2018年11月07日
    Award of the Berlin Science Prize 2018

    07 November 2018, Berlin: Daniela Rupp, Leibnitz Young Investigators Group Leader at the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy, is at the award ceremony for the Berlin Science Prize 2018 and the Young Investigators Prize 2018 in the Rotes Rathaus. Rupp was awarded the Young Investigators Prize 2018 of the Berlin Science Prize for her current research in attosecond physics, also known as ultra-short time physics. In a number of projects, she and her team have been able to make progress in understanding the imaging and interaction of nanometer-sized particles using intense X-ray pulses. Photo: Christoph Soeder/dpa、クレジット:DPA/共同通信イメージズ

    商品コード: 2018110924653

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902051

  • 2020年04月08日
    JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxides

    Respilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902036

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902038

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902061

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902066

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902063

  • 2020年04月08日
    JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxides

    Respilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902035

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902067

  • 2020年04月08日
    JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxides

    Respilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902057

  • 2020年04月08日
    Company Respilon, face mask, with copper oxides

    Respilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902074

  • 2020年04月08日
    JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxides

    Respilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット:CTK/共同通信イメージズ

    商品コード: 2020040902055

  • 2020年09月07日
    渋谷工業とスディックスバイオがPCR検査装置開発で会見

    渋谷工業はスディックスバイオテック(鹿児島市)と共同で、一つの唾液検体から新型コロナウイルスとインフルエンザウイルスA型・B型の感染を15分程度で診断できる世界初のPCR検査装置を開発し、年内をめどに発売する。価格は未定だが「開業医でも購入できる」(隅田泰生スディックスバイオテック社長)200万円以下を目指し、初年度は数百台の販売を見込む。スディックスバイオテックは鹿児島大学発のベンチャーで、唾液から検体を採取する独自のウイルスの検査方法「糖鎖固定化磁性金ナノ粒子(SMGNP)法」を開発している。同検査法は検体の前処理工程を3分程度で完了するため、新開発するPCR検査装置との併用で従来法から大幅に検査時間を短縮できる。また、一度に8検体の検査が可能な小型の装置に仕上げ、個人の開業医院での運用を同時に提案していく。装置は渋谷工業が製造し、国内販売はスディックスバイオテック、海外販売は渋谷工業が行う。写真は握手する毛利克己渋谷工業専務(左)と隅田泰生スディックスバイオテック社長 =2020(令和2)年9月7日撮影、撮影場所不明、クレジット:日刊工業新聞/共同通信イメージズ

    商品コード: 2020091805148

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) and Manager Director of Pfizer Puurs, Luc Van Steenwinkel (R) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106281

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (C) and Manager Director of Pfizer Puurs, Luc Van Steenwinkel (R) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106373

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106344

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040104882

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702527

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107143

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107110

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702598

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702517

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107878

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702495

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107741

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702499

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107843

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702422

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106385

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106205

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107796

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - Belgium

    King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040702605

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033107287

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106269

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106548

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040105172

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106552

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106576

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106371

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs , Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106424

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs , Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106369

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106561

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106411

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (not seen) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106259

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (not seen) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106375

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (not seen) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106381

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106447

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106539

  • 2021年03月30日
    King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

    King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM=2021(令和3)年3月30日、クレジット:Reporters/ABACA/共同通信イメージズ

    商品コード: 2021040106066

  • 2021年03月30日
    King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.

    March 30, 2021, PUURS, Belgium: King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット:©Reporters via ZUMA Press/共同通信イメージズ ※Europe Rights OUT

    商品コード: 2021033106523

  • 2021年06月14日
    COVID-19: MEDICAL: Vaccine Candidates

    June 14, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), an American biotechnology company, is displayed on smartphone in front of waving flag of United States, visual representation of virus, medical syringe and ampoules with label COVID-19 vaccine. Novavax, today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. (Credit Image: © Andre M. Chang/ZUMA Wire)、クレジット:©Andre M. Chang/ZUMA Wire/共同通信イメージズ

    商品コード: 2021061510181

  • 2021年06月14日
    COVID-19: MEDICAL: Vaccine Candidates

    June 14, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), an American biotechnology company, is displayed on smartphone in front of waving flag of United States, visual representation of virus, medical syringe and ampoules with label COVID-19 vaccine. Novavax, today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. (Credit Image: © Andre M. Chang/ZUMA Wire)、クレジット:©Andre M. Chang/ZUMA Wire/共同通信イメージズ

    商品コード: 2021061510061

  • 2021年07月09日
    Expedition 65 SpaceX Crew 2 Aboard Space Station

    Expedition 65 Flight Engineer THOMAS PESQUET of ESA (European Space Agency) conducts a session for the InSPACE-4 physics study. The space manufacturing investigation takes place inside the Microgravity Science Glovebox and explores ways to harness nanoparticles to fabricate new and advanced materials.、クレジット:Expedition 65 Flight Engineer THOMAS PESQUET of ESA (European Space Agency/共同通信イメージズ

    商品コード: 2021071605867

  • 2021年08月10日
    Clinical trial of S. Korea‘s 1st homegrown vaccine candidate

    Clinical trial of S. Korea‘s 1st homegrown vaccine candidate This file photo dated Oct. 15, 2020, shows vials of the coronavirus vaccine candidate revealed during a press conference at SK Bioscience Co., a vaccine development company, in Seongnam, south of Seoul. On Aug. 10, 2021, the government said SK has won approval to conduct the phase three clinical trial of the country‘s first homegrown vaccine candidate, GBP510, a recombinant-protein vaccine based on novel two-component nanoparticles that can maximize the immune effect. (Yonhap)/2021-08-10 16:15:28/<Copyright ⓒ 1980-2021 YONHAPNEWS AGENCY. All rights reserved.>=クレジット:Yonhap News Agency/共同通信イメージズ

    商品コード: 2021081105816

  • 1